|
1. Haslam DW, James WP. Obesity. Lancet 2005, 366(9492): 1197-1209.
2. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. International journal of obesity 2008, 32(9): 1431-1437.
3. Das UN. Obesity: genes, brain, gut, and environment. Nutrition 2010, 26(5): 459-473.
4. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nature reviews Immunology 2011, 11(2): 98-107.
5. Shoelson SE, Goldfine AB. Getting away from glucose: fanning the flames of obesity-induced inflammation. Nature medicine 2009, 15(4): 373-374.
6. Tanti JF, Jager J. Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Current opinion in pharmacology 2009, 9(6): 753-762.
7. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends in endocrinology and metabolism: TEM 2000, 11(8): 327-332.
8. Ailhaud G. Adipose tissue as an endocrine organ. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000, 24 Suppl 2: S1-3.
9. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochemical Society transactions 2005, 33(Pt 5): 1078-1081.
10. Cartier A, Cote M, Bergeron J, Almeras N, Tremblay A, Lemieux I, et al. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity. Clinical endocrinology 2010, 72(3): 349-357.
11. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. The Journal of clinical endocrinology and metabolism 1998, 83(3): 847-850.
12. Yudkin JS, Coppack SW, Bulmer K, Rawesh A, Mohamed-Ali V. Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivo. Thrombosis research 1999, 96(1): 1-9.
13. Waserman S, Dolovich J, Conway M, Marshall JS. TNF-alpha dysregulation in asthma: relationship to ongoing corticosteroidtherapy. Canadian respiratory journal : journal of the Canadian Thoracic Society 2000, 7(3): 229-237.
14. Moelants EA, Mortier A, Van Damme J, Proost P. Regulation of TNF-alpha with a focus on rheumatoid arthritis. Immunology and cell biology 2013, 91(6): 393-401.
15. Brynskov J, Foegh P, Pedersen G, Ellervik C, Kirkegaard T, Bingham A, et al. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut 2002, 51(1): 37-43.
16. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American journal of physiology Endocrinology and metabolism 2001, 280(5): E745-751.
17. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin--a key adipokine in the metabolic syndrome. Diabetes, obesity & metabolism 2006, 8(3): 264-280.
18. Sivan E, Whittaker PG, Sinha D, Homko CJ, Lin M, Reece EA, et al. Leptin in human pregnancy: the relationship with gestational hormones. American journal of obstetrics and gynecology 1998, 179(5): 1128-1132.
19. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nature medicine 2012, 18(3): 363-374.
20. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56(1): 16-23.
21. Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, Kanatani Y, et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009, 58(11): 2574-2582.
22. Gnacinska M, Malgorzewicz S, Stojek M, Lysiak-Szydlowska W, Sworczak K. Role of adipokines in complications related to obesity: a review. Advances in medical sciences 2009, 54(2): 150-157.
23. Anderson KV, Jurgens G, Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 1985, 42(3): 779-789.
24. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406(6797): 782-787.
25. Fresno M, Alvarez R, Cuesta N. Toll-like receptors, inflammation, metabolism and obesity. Archives of physiology and biochemistry 2011, 117(3): 151-164.
26. Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes & development 2007, 21(12): 1443-1455.
27. Dasu MR, Jialal I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. American journal of physiology Endocrinology and metabolism 2011, 300(1): E145-154.
28. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature reviews Immunology 2007, 7(5): 353-364.
29. Osborn O, Oh DY, McNelis J, Sanchez-Alavez M, Talukdar S, Lu M, et al. G protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice. The Journal of clinical investigation 2012, 122(7): 2444-2453.
30. Sun WL, Chen LL, Zhang SZ, Wu YM, Ren YZ, Qin GM. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis. Internal medicine 2011, 50(15): 1569-1574.
31. Kant P, Hull MA. Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nature reviews Gastroenterology & hepatology 2011, 8(4): 224-238.
32. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Molecular and cellular endocrinology 2010, 314(1): 1-16.
33. Lebrun P, Van Obberghen E. SOCS proteins causing trouble in insulin action. Acta physiologica 2008, 192(1): 29-36.
34. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. The Journal of clinical investigation 1999, 103(2): 253-259.
35. Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 2005, 54(12): 3458-3465.
36. Hotamisligil GS. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 2005, 54 Suppl 2: S73-78.
37. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000, 49(11): 1939-1945.
38. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of clinical investigation 2006, 116(11): 3015-3025.
39. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. The Journal of biological chemistry 2002, 277(52): 50230-50236.
40. Liao PC, Kuo DC, Lin CC, Ho KC, Lin TP, Hwang SY. Historical spatial range expansion and a very recent bottleneck of Cinnamomum kanehirae Hay. (Lauraceae) in Taiwan inferred from nuclear genes. BMC evolutionary biology 2010, 10: 124.
41. Huang CC, Cheng HH, Wang JL, Cheng JS, Chai KL, Fang YC, et al. Effects of Antrodia camphorata extracts on the viability, apoptosis, [Ca2+]i, and MAPKs phosphorylation of OC2 human oral cancer cells. The Chinese journal of physiology 2009, 52(3): 128-135.
42. Yang HL, Kuo YH, Tsai CT, Huang YT, Chen SC, Chang HW, et al. Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2011, 49(1): 290-298.
43. Huang CH, Chang YY, Liu CW, Kang WY, Lin YL, Chang HC, et al. Fruiting body of Niuchangchih (Antrodia camphorata) protects livers against chronic alcohol consumption damage. Journal of agricultural and food chemistry 2010, 58(6): 3859-3866.
44. Lu MC, Du YC, Chuu JJ, Hwang SL, Hsieh PC, Hung CS, et al. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. Archives of toxicology 2009, 83(2): 121-129.
45. Chang JM, Lee YR, Hung LM, Liu SY, Kuo MT, Wen WC, et al. An Extract of Antrodia camphorata Mycelia Attenuates the Progression of Nephritis in Systemic Lupus Erythematosus-Prone NZB/W F1 Mice. Evidence-based complementary and alternative medicine : eCAM 2011, 2011: 465894.
46. Wu MD, Cheng MJ, Yech YJ, Yuan GF, Chen JJ. Inhibitory effects of maleimide derivatives from the mycelia of the fungus Antrodia cinnamomea BCRC 36799 on nitric oxide production in lipopolysaccharide (LPS)-activated RAW264.7 macrophages. Chemistry & biodiversity 2013, 10(3): 434-441.
47. Suk FM, Lin SY, Chen CH, Yen SJ, Su CH, Liu DZ, et al. Taiwanofungus camphoratus activates peroxisome proliferator-activated receptors and induces hypotriglyceride in hypercholesterolemic rats. Bioscience, biotechnology, and biochemistry 2008, 72(7): 1704-1713.
48. Lai MN, Ko HJ, Ng LT. Hypolipidemic Effects of Antrodia Cinnamomea Extracts in High-Fat Diet-Fed Hamsters. J Food Biochem 2012, 36(2): 233-239.
49. Wree A, Mayer A, Westphal S, Beilfuss A, Canbay A, Schick RR, et al. Adipokine expression in brown and white adipocytes in response to hypoxia. Journal of endocrinological investigation 2012, 35(5): 522-527.
50. Wang B, Wood IS, Trayhurn P. Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes. The Journal of endocrinology 2008, 198(1): 127-134.
51. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998, 395(6704): 763-770.
52. Jarchum I, Pamer EG. Regulation of innate and adaptive immunity by the commensal microbiota. Current opinion in immunology 2011, 23(3): 353-360.
53. Bech-Nielsen GV, Hansen CH, Hufeldt MR, Nielsen DS, Aasted B, Vogensen FK, et al. Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity. Research in veterinary science 2012, 92(3): 501-508.
54. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Science translational medicine 2009, 1(6): 6ra14.
55. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell host & microbe 2008, 3(4): 213-223.
56. Greiner T, Backhed F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends in endocrinology and metabolism: TEM 2011, 22(4): 117-123.
57. Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PloS one 2012, 7(10): e47713.
|